STOCK TITAN

[Form 4] Ainos, Inc. Warrants Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

ASE Test Inc, a 10% owner of Ainos Inc (AIMD), reported a significant insider transaction on June 23, 2025. The company acquired 29,476 shares of common stock through a Share Exchange Agreement with Taiwan Carbon Nano Technology Corporation.

Key transaction details:

  • Acquired shares in exchange for 5,687,109 ordinary shares of Ainos Inc. (Cayman Islands)
  • Exchange value approximately $0.497 per share
  • Total beneficial ownership following transaction: 58,887 shares
  • Ownership form: Direct through ASE Test, indirect through ASE Technology Holding Co., Ltd

This Form 4 filing indicates a strategic share exchange transaction that increases ASE Test's stake in Ainos Inc. The transaction was executed through a formal agreement dated June 3, 2025, demonstrating continued institutional investment interest in the company.

ASE Test Inc, detentrice del 10% di Ainos Inc (AIMD), ha comunicato una significativa operazione interna il 23 giugno 2025. La società ha acquisito 29.476 azioni ordinarie tramite un Accordo di Scambio Azionario con Taiwan Carbon Nano Technology Corporation.

Dettagli principali dell'operazione:

  • Azioni acquisite in cambio di 5.687.109 azioni ordinarie di Ainos Inc. (Isole Cayman)
  • Valore dello scambio circa 0,497$ per azione
  • Totale partecipazione dopo l'operazione: 58.887 azioni
  • Forma di partecipazione: diretta tramite ASE Test, indiretta tramite ASE Technology Holding Co., Ltd

Questa comunicazione Form 4 indica una transazione strategica di scambio azionario che incrementa la quota di ASE Test in Ainos Inc. L'operazione è stata realizzata tramite un accordo formale datato 3 giugno 2025, dimostrando un continuo interesse di investimento istituzionale nella società.

ASE Test Inc, propietario del 10% de Ainos Inc (AIMD), informó una transacción interna significativa el 23 de junio de 2025. La empresa adquirió 29,476 acciones ordinarias mediante un Acuerdo de Intercambio de Acciones con Taiwan Carbon Nano Technology Corporation.

Detalles clave de la transacción:

  • Acciones adquiridas a cambio de 5,687,109 acciones ordinarias de Ainos Inc. (Islas Caimán)
  • Valor del intercambio aproximadamente $0.497 por acción
  • Propiedad total beneficiaria tras la transacción: 58,887 acciones
  • Forma de propiedad: directa a través de ASE Test, indirecta a través de ASE Technology Holding Co., Ltd

Esta presentación del Formulario 4 indica una transacción estratégica de intercambio de acciones que incrementa la participación de ASE Test en Ainos Inc. La operación se ejecutó mediante un acuerdo formal fechado el 3 de junio de 2025, demostrando un interés continuo de inversión institucional en la compañía.

ASE Test IncAinos Inc (AIMD)의 10% 지분 보유자로서 2025년 6월 23일 중요한 내부 거래를 보고했습니다. 이 회사는 Taiwan Carbon Nano Technology Corporation과의 주식 교환 계약을 통해 29,476주의 보통주를 취득했습니다.

주요 거래 내용:

  • Ainos Inc. (케이맨 제도)의 보통주 5,687,109주와 교환하여 주식 취득
  • 교환 가치 약 주당 $0.497
  • 거래 후 총 실질 소유 주식: 58,887주
  • 소유 형태: ASE Test를 통한 직접 소유, ASE Technology Holding Co., Ltd를 통한 간접 소유

이 Form 4 제출은 ASE Test가 Ainos Inc.에서 지분을 늘리는 전략적 주식 교환 거래임을 나타냅니다. 이 거래는 2025년 6월 3일자 공식 계약을 통해 실행되었으며, 회사에 대한 지속적인 기관 투자 관심을 보여줍니다.

ASE Test Inc, propriétaire de 10% de Ainos Inc (AIMD), a déclaré une transaction d’initié significative le 23 juin 2025. La société a acquis 29 476 actions ordinaires via un accord d’échange d’actions avec Taiwan Carbon Nano Technology Corporation.

Détails clés de la transaction :

  • Actions acquises en échange de 5 687 109 actions ordinaires d’Ainos Inc. (Îles Caïmans)
  • Valeur d’échange d’environ 0,497 $ par action
  • Participation totale bénéficiaire après la transaction : 58 887 actions
  • Forme de détention : directe via ASE Test, indirecte via ASE Technology Holding Co., Ltd

Ce dépôt au formulaire 4 indique une transaction stratégique d’échange d’actions augmentant la participation d’ASE Test dans Ainos Inc. La transaction a été réalisée par un accord formel daté du 3 juin 2025, démontrant un intérêt institutionnel continu pour l’investissement dans l’entreprise.

ASE Test Inc, ein 10%iger Eigentümer von Ainos Inc (AIMD), meldete am 23. Juni 2025 eine bedeutende Insider-Transaktion. Das Unternehmen erwarb 29.476 Stammaktien durch eine Aktienaustauschvereinbarung mit der Taiwan Carbon Nano Technology Corporation.

Wichtige Transaktionsdetails:

  • Erworbene Aktien im Tausch gegen 5.687.109 Stammaktien von Ainos Inc. (Kaimaninseln)
  • Tauschwert ca. 0,497 $ pro Aktie
  • Gesamtbeteiligung nach der Transaktion: 58.887 Aktien
  • Besitzform: Direkt über ASE Test, indirekt über ASE Technology Holding Co., Ltd

Diese Form 4-Meldung weist auf eine strategische Aktienaustauschtransaktion hin, die den Anteil von ASE Test an Ainos Inc. erhöht. Die Transaktion wurde durch eine formelle Vereinbarung vom 3. Juni 2025 durchgeführt und zeigt ein anhaltendes institutionelles Investitionsinteresse am Unternehmen.

Positive
  • None.
Negative
  • None.

ASE Test Inc, detentrice del 10% di Ainos Inc (AIMD), ha comunicato una significativa operazione interna il 23 giugno 2025. La società ha acquisito 29.476 azioni ordinarie tramite un Accordo di Scambio Azionario con Taiwan Carbon Nano Technology Corporation.

Dettagli principali dell'operazione:

  • Azioni acquisite in cambio di 5.687.109 azioni ordinarie di Ainos Inc. (Isole Cayman)
  • Valore dello scambio circa 0,497$ per azione
  • Totale partecipazione dopo l'operazione: 58.887 azioni
  • Forma di partecipazione: diretta tramite ASE Test, indiretta tramite ASE Technology Holding Co., Ltd

Questa comunicazione Form 4 indica una transazione strategica di scambio azionario che incrementa la quota di ASE Test in Ainos Inc. L'operazione è stata realizzata tramite un accordo formale datato 3 giugno 2025, dimostrando un continuo interesse di investimento istituzionale nella società.

ASE Test Inc, propietario del 10% de Ainos Inc (AIMD), informó una transacción interna significativa el 23 de junio de 2025. La empresa adquirió 29,476 acciones ordinarias mediante un Acuerdo de Intercambio de Acciones con Taiwan Carbon Nano Technology Corporation.

Detalles clave de la transacción:

  • Acciones adquiridas a cambio de 5,687,109 acciones ordinarias de Ainos Inc. (Islas Caimán)
  • Valor del intercambio aproximadamente $0.497 por acción
  • Propiedad total beneficiaria tras la transacción: 58,887 acciones
  • Forma de propiedad: directa a través de ASE Test, indirecta a través de ASE Technology Holding Co., Ltd

Esta presentación del Formulario 4 indica una transacción estratégica de intercambio de acciones que incrementa la participación de ASE Test en Ainos Inc. La operación se ejecutó mediante un acuerdo formal fechado el 3 de junio de 2025, demostrando un interés continuo de inversión institucional en la compañía.

ASE Test IncAinos Inc (AIMD)의 10% 지분 보유자로서 2025년 6월 23일 중요한 내부 거래를 보고했습니다. 이 회사는 Taiwan Carbon Nano Technology Corporation과의 주식 교환 계약을 통해 29,476주의 보통주를 취득했습니다.

주요 거래 내용:

  • Ainos Inc. (케이맨 제도)의 보통주 5,687,109주와 교환하여 주식 취득
  • 교환 가치 약 주당 $0.497
  • 거래 후 총 실질 소유 주식: 58,887주
  • 소유 형태: ASE Test를 통한 직접 소유, ASE Technology Holding Co., Ltd를 통한 간접 소유

이 Form 4 제출은 ASE Test가 Ainos Inc.에서 지분을 늘리는 전략적 주식 교환 거래임을 나타냅니다. 이 거래는 2025년 6월 3일자 공식 계약을 통해 실행되었으며, 회사에 대한 지속적인 기관 투자 관심을 보여줍니다.

ASE Test Inc, propriétaire de 10% de Ainos Inc (AIMD), a déclaré une transaction d’initié significative le 23 juin 2025. La société a acquis 29 476 actions ordinaires via un accord d’échange d’actions avec Taiwan Carbon Nano Technology Corporation.

Détails clés de la transaction :

  • Actions acquises en échange de 5 687 109 actions ordinaires d’Ainos Inc. (Îles Caïmans)
  • Valeur d’échange d’environ 0,497 $ par action
  • Participation totale bénéficiaire après la transaction : 58 887 actions
  • Forme de détention : directe via ASE Test, indirecte via ASE Technology Holding Co., Ltd

Ce dépôt au formulaire 4 indique une transaction stratégique d’échange d’actions augmentant la participation d’ASE Test dans Ainos Inc. La transaction a été réalisée par un accord formel daté du 3 juin 2025, démontrant un intérêt institutionnel continu pour l’investissement dans l’entreprise.

ASE Test Inc, ein 10%iger Eigentümer von Ainos Inc (AIMD), meldete am 23. Juni 2025 eine bedeutende Insider-Transaktion. Das Unternehmen erwarb 29.476 Stammaktien durch eine Aktienaustauschvereinbarung mit der Taiwan Carbon Nano Technology Corporation.

Wichtige Transaktionsdetails:

  • Erworbene Aktien im Tausch gegen 5.687.109 Stammaktien von Ainos Inc. (Kaimaninseln)
  • Tauschwert ca. 0,497 $ pro Aktie
  • Gesamtbeteiligung nach der Transaktion: 58.887 Aktien
  • Besitzform: Direkt über ASE Test, indirekt über ASE Technology Holding Co., Ltd

Diese Form 4-Meldung weist auf eine strategische Aktienaustauschtransaktion hin, die den Anteil von ASE Test an Ainos Inc. erhöht. Die Transaktion wurde durch eine formelle Vereinbarung vom 3. Juni 2025 durchgeführt und zeigt ein anhaltendes institutionelles Investitionsinteresse am Unternehmen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ASE Test, Inc.

(Last) (First) (Middle)
10 WEST FIFTH STREET, NANZIH DISTRICT

(Street)
KAOHSIUNG F5 00000

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 06/23/2025 P 29,476 A (1) 58,887(2) D(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. ASE Test, Inc. ("ASE Test"), the reporting person acquired the shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") pursuant to the Share Exchange Agreement that was made and entered into as of June 3, 2025 by and between ASE Test and Taiwan Carbon Nano Technology Corporation, in exchange for 5,687,109 ordinary shares of Ainos Inc., a Cayman Islands company, having an approximate fair market value of $0.497 per share.
2. The shares of Common Stock of the Issuer reported herein are directly held by ASE Test, an indirectly wholly-owned subsidiary of ASE Technology Holding Co., Ltd. Accordingly, ASE Technology Holding Co., Ltd. is reporting indirect ownership of the securities held by ASE Test.
/s/ Alan Li, By: ASE Test, Inc., By: Alan Li, authorized signatory of ASE Test, Inc. 06/25/2025
/s/ Joseph Tung, authorized signatory of ASE Technology Holding Co., Ltd. 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of AIMDW (Ainos, Inc.) did ASE Test acquire on June 23, 2025?

ASE Test acquired 29,476 shares of Ainos, Inc. common stock (AIMDW) on June 23, 2025 through a Share Exchange Agreement.

What was the transaction price for ASE Test's acquisition of AIMDW shares?

The shares were acquired in exchange for 5,687,109 ordinary shares of Ainos Inc. (Cayman Islands company) with an approximate fair market value of $0.497 per share, as part of a Share Exchange Agreement dated June 3, 2025.

How many AIMDW shares does ASE Test own after the June 23, 2025 transaction?

Following the reported transaction, ASE Test directly owns 58,887 shares of Ainos, Inc. (AIMDW) common stock.

Who is the ultimate beneficial owner of the AIMDW shares held by ASE Test?

ASE Technology Holding Co., Ltd. is the ultimate beneficial owner of the shares, as ASE Test is its indirectly wholly-owned subsidiary. ASE Technology Holding Co., Ltd. reports indirect ownership of the securities held by ASE Test.

What is ASE Test's relationship to AIMDW (Ainos, Inc.)?

According to the Form 4 filing, ASE Test is a 10% Owner of Ainos, Inc. (AIMDW), making it a significant shareholder of the company.
AINOS INC

NASDAQ:AIMDW

AIMDW Rankings

AIMDW Latest News

AIMDW Latest SEC Filings

AIMDW Stock Data

17.22M
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO